Olanzapine Tablet, Film Coated
Product Images NDC 55154-6889

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 55154-6889). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

3dd0be68 E71b 4a74 9899 71de1d6b50d1 00

The text describes a unit dose package of Olanzapine Tablets, with each film-coated tablet containing 10mg of Olanzapine USP. The product insert should be consulted for complete dosage information, prescribing information, precautions and warnings. The medication should be stored at a controlled room temperature of 20° to 25° C (68° to 77° F). The package is not child-resistant and should be kept out of the reach of children. The drug is distributed by Major Pharmaceuticals and Cardinal Health.*

FDA Label Image

3dd0be68 E71b 4a74 9899 71de1d6b50d1 01

This is a packaging for Olanzapine Tablets, USP 5mg from Major Pharmaceuticals. It contains 10 film-coated tablets and is intended for institutional use only. It is important to keep the medication out of reach of children and to dispense it in a tight, light-resistant container. The dosage information, prescribing information, precautions, and warnings are available on the product insert or medguide found at the manufacturer's website. The medication should be stored at a controlled room temperature of 20° to 25° C. The package is distributed by Cardinal Health.*

FDA Label Image

Structure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.